retatrutide shot Demand for Unapproved Weight-Loss Drug Surges on Social Media Phase III retatrutide study demonstrates

A lower 4mg weekly dose also resulted in impressive weight loss results, with an average loss of 17% over 48 weeks and: 92% of participants lost at least 5% of their starting body weight 75% lost at least 10% of their body weight 60% lost at least 15% of their starting weight Retatrutide vs Mounjaro In clinical trials, the active ingredient in Mounjaro, tirzepatide, results in an average weight loss of 22.5% at the highest 15mg per week dose over 72 weeks

Youre moving your body, youre going for the phytochemicals, youre going for good proteins, youre getting your circadian rhythm back

Summer storage tips During hot months, pay extra attention to delivery timing

Rekha Kumar, MS, MD, endocrinologist, obesity medicine specialist and senior medical advisor at Found, describes Eli Lillys retatrutide (nicknamed reta) as a next-generation weight-loss medication that is still awaiting FDA approval, but currently in late-stage clinical trials

doi: 10.2337/diabetes.49.6.896